Our Company

Home
Our Company

At Ironwood, we are committed to finding new treatments for patients living with GI diseases

Who is Ironwood?

Our vision is clear: bring new, differentiated therapies to the millions of patients who live with GI diseases.

Building on a strong, decades-long foundation, the next leg of our journey continues with three innovative assets. Our in-market product, LINZESS® (linaclotide), discovered in-house, is the branded prescription market leader in its class. We are also pioneering the science behind our two development programs, IW-3718 and MD-7246, which aim to address two highly symptomatic conditions with significant unmet needs.

We believe we have what it takes to achieve our vision and we’re all in. Together, we’re paving a path to long-term success.

I love waking up every day knowing how invested everyone is in the success of the company.”

Aleko Verrios, Regional Sales Manager, California North

I am excited about the opportunity to be GI-focused and to bring exciting new therapies to our trusted GI community.”

Robin May, Clinical Sales Specialist, Jefferson City, MO

Everyone at Ironwood is a true owner of the company. The ownership mindset extends beyond the home office and out into the field sales organization. Being an owner, I am interested in the entire company doing well, not just myself or my team.”

Stacy Pokrywka, Regional Sales Manager, Great Lakes

Join Us

When you join Ironwood, you join more than just a company.

View Open Positions

LINZESS®, CONSTELLA®, IRONWOOD® and their associated logos are trademarks of Ironwood Pharmaceuticals, Inc. Any other trademarks referred to herein are the property of their respective owners. All rights reserved.

Who is Ironwood?

You are now leaving www.IronwoodPharma.com.